Mphasis Board Responds to SEBI Compliance Notice for Chairperson Appointment Delay

2 min read     Updated on 28 Mar 2026, 09:01 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Mphasis Board addressed alleged SEBI Regulation 17(1) non-compliance for Q3 FY26, facing Rs. 1,23,900 in fines from exchanges for 21-day chairperson vacancy. The company clarified no board meetings occurred during December 11, 2025 to January 6, 2026 transition period, with new chairperson appointed January 7, 2026. Waiver applications submitted to BSE and NSE on March 13, 2026, with outcomes pending.

powered bylight_fuzz_icon
36214316

*this image is generated using AI for illustrative purposes only.

Mphasis Limited's Board of Directors has formally responded to regulatory notices regarding alleged non-compliance with SEBI listing regulations during the quarter ended December 31, 2025. The IT services company received notices from both BSE and NSE on February 27, 2026, highlighting concerns over board composition requirements.

Regulatory Non-Compliance Details

Both stock exchanges identified non-compliance with Regulation 17(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically related to board composition and chairperson appointment requirements. The alleged non-compliance period extended for 21 days, resulting in significant financial penalties.

Parameter Details
Non-compliance Period 21 days
Fine per Day Rs. 5,000
Basic Fine Amount Rs. 1,05,000
GST (18%) Rs. 18,900
Total Fine Payable Rs. 1,23,900

Board's Response and Clarifications

During the Board meeting held on March 27, 2026, directors deliberated on the matter and provided detailed explanations for the transition period. The Board emphasized that the selection and appointment of a chairperson requires careful consideration given the significant competence, skill, experience, and seniority demands of the role.

Key points highlighted by the Board include:

  • No Board meetings were convened during the period from December 11, 2025, to January 6, 2026
  • No requirement for a chairperson to preside during this period due to absence of meetings
  • Governance operations remained unaffected and Board functioning was not impaired
  • The company maintains a practice of electing regular Non-Executive Chairpersons

Timeline of Events

The company provided a clear timeline of events surrounding the chairperson transition:

Date Event
December 11, 2025 Start of transition period
January 6, 2026 End of transition period
January 7, 2026 New Chairperson appointed
January 22, 2026 First Board meeting with new Chairperson
February 27, 2026 Regulatory notices received
March 13, 2026 Waiver applications submitted
March 27, 2026 Board meeting to address notices

Waiver Application and Next Steps

Mphasis submitted waiver applications to both BSE and NSE on March 13, 2026, seeking relief from the imposed penalties. The company is currently awaiting the outcome of these applications. The exchanges had provided 15 days from the notice date for fine payment, failing which they threatened to initiate actions including freezing of promoter shareholdings and potential transfer to Z category for trading restrictions.

Commitment to Compliance

The company has reiterated its commitment to maintaining full compliance with all SEBI and stock exchange requirements. Mphasis emphasized that it continuously maintains compliance with Regulation 17 of SEBI Listing Regulations and that the interim transition period should not necessitate inducting additional Independent Directors.

The Board's response demonstrates the company's proactive approach to addressing regulatory concerns while maintaining that governance standards were not compromised during the transition period. The outcome of the waiver applications will determine whether the company needs to pay the imposed fines or receives relief from the exchanges.

Historical Stock Returns for Mphasis

1 Day5 Days1 Month6 Months1 Year5 Years
-0.71%-0.32%-6.23%-22.09%-16.47%+26.53%

Will the stock exchanges approve Mphasis' waiver applications, and what precedent might this set for other companies facing similar board transition issues?

How might this regulatory scrutiny impact Mphasis' corporate governance practices and board appointment processes going forward?

Could this compliance issue affect Mphasis' institutional investor confidence or ESG ratings in the near term?

Mphasis Limited Board Meeting Scheduled for April 29, 2026 to Consider Q4FY26 Results

2 min read     Updated on 27 Mar 2026, 10:19 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Mphasis Limited has announced its board meeting for April 29, 2026, to review Q4FY26 and annual financial results under SEBI regulations. The company has implemented trading window restrictions from March 23 to May 1, 2026, and scheduled an earnings conference call for April 30, 2026, demonstrating commitment to transparent investor communication.

powered bylight_fuzz_icon
36174393

*this image is generated using AI for illustrative purposes only.

Mphasis Limited has formally notified the stock exchanges about its upcoming board meeting scheduled for April 29, 2026, to review and approve the company's financial performance for the fourth quarter and full year ended March 31, 2026. The announcement was made through an official communication to both BSE Limited and National Stock Exchange of India Limited on March 27, 2026.

Board Meeting Agenda and Timeline

The board meeting will focus on several key agenda items as outlined in the company's regulatory filing pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015:

Meeting Details: Information
Date: Wednesday, April 29, 2026
Primary Agenda: Audited standalone and consolidated financial results
Period Covered: Quarter and year ended March 31, 2026
Additional Matters: Dividend recommendation and other business
Auditor's Report: To be considered along with financial results

Trading Window Restrictions

In accordance with SEBI regulations on insider trading prevention, Mphasis has implemented mandatory trading restrictions for company securities. The trading window closure affects all stakeholders who may have access to unpublished price-sensitive information.

Trading Window Status: Timeline
Closure Period: March 23, 2026 to May 1, 2026 (both days inclusive)
Reopening Date: Saturday, May 2, 2026
Regulatory Basis: SEBI Insider Trading Regulations, 2015
Company Policy: Code of Conduct for Prevention of Insider Trading

Investor Engagement Initiative

Mphasis has scheduled a dedicated earnings conference call to discuss the financial results with the investment community. This initiative demonstrates the company's commitment to transparent communication with stakeholders.

Conference Call Details: Information
Date: April 30, 2026
Timing: 8:30 AM Indian Standard Time
Participants: Investors and Analysts
Additional Details: To be communicated separately

Regulatory Compliance and Documentation

The board meeting notification has been issued pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication was signed by Mayank Verma, Senior Vice President and Company Secretary (Membership No.: ACS 18776), ensuring proper corporate governance protocols are followed. All relevant information has been made available on the company's official website at www.mphasis.com for stakeholder reference.

Historical Stock Returns for Mphasis

1 Day5 Days1 Month6 Months1 Year5 Years
-0.71%-0.32%-6.23%-22.09%-16.47%+26.53%

What market expectations are analysts setting for Mphasis's Q4 2026 revenue growth given the current IT services industry trends?

How might potential dividend announcements impact Mphasis's stock valuation and investor sentiment in the upcoming quarter?

What strategic initiatives or business expansions could Mphasis announce during the earnings call to drive future growth?

More News on Mphasis

1 Year Returns:-16.47%